Buy Stocks Easy | About Us
January 29, 2022
Buy Stocks Easy | Online Stocks

ADMS


Buy Adamas Pharmaceuticals, Inc. Stock (symbol: ADMS) Easy Online

Company Name: Adamas Pharmaceuticals, Inc.

Symbol: ADMS

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

ADMS Current Share Price

Today's ADMS ( Adamas Pharmaceuticals, Inc. ) opening price: $3.6700

Yesterday's ADMS ( Adamas Pharmaceuticals, Inc. ) closing price: $3.6700

Adamas Pharmaceuticals, Inc. Stock ( symbol: ADMS ) Price Chart since IPO (2014):

12 Months Adamas Pharmaceuticals, Inc. Stock ( symbol: ADMS ) Price Chart

Popular Questions about Adamas Pharmaceuticals, Inc. Public Stock ( ADMS )

A: Adamas Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is ADMS

A: Adamas Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2014

A: Adamas Pharmaceuticals, Inc.'s stock (ADMS symbol) price at ther IPO (initial Public Offering) was $3.6700

Q: Is ADMS stock worth buying at the moment?

A: The ADMS stock performance since 2019 are rather disappointing. If you had bought 1 share of Adamas Pharmaceuticals, Inc. stock (symbol: ADMS) at the beginning of 2019, at the opening share price of $9.0000, you would be left with exactly $3.6700 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Adamas Pharmaceuticals, Inc. Stock Easy Online

Adamas Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:





Adamas Pharmaceuticals, Inc. Stock Price Yesterday



 


Adamas Pharmaceuticals, Inc. Stock Price – Last Week




 


Adamas Pharmaceuticals, Inc. Stock Price – Last Month




 


Adamas Pharmaceuticals, Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961609/0/en/Adamas-Announces-Top-Line-Results-from-INROADS-Phase-3-Trial-of-ADS-5102-for-Multiple-Sclerosis-Patients-with-Walking-Impairment.html
                            

                                
Adamas Announces Top-Line Results from INROADS Phase 3 Trial of ADS-5102 for Multiple Sclerosis Patients with Walking Impairment

                                
                                
- INROADS study achieved its primary endpoint (proportion of respon...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4311060-adamas-pharmaceuticals-inroads-data-will-make-break-2019
                            

                                
Adamas Pharmaceuticals: INROADS Data Will Make Or Break 2019

                                
                                
Adamas Pharmaceuticals: INROADS Data Will Make Or Break 2019


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/655797/implied-volatility-surging-for-adamas-pharmaceuticals-adms-stock-options
                            

                                
Implied Volatility Surging for Adamas Pharmaceuticals (ADMS) Stock Options

                                
                                
Investors need to pay close attention to Adamas Pharmaceuticals (AD...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/21/1951089/0/en/Adamas-to-Present-at-Upcoming-Evercore-ISI-and-Piper-Jaffray-Investor-Conferences.html
                            

                                
Adamas to Present at Upcoming Evercore ISI and Piper Jaffray Investor Conferences

                                
                                
EMERYVILLE, Calif., Nov.  21, 2019  (GLOBE NEWSWIRE) -- Adamas Phar...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4304099-adamas-pharmaceuticals-inc-adms-ceo-neil-mcfarlane-q3-2019-results-earnings-call-transcript
                            

                                
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 2019 Results - Earnings Call Transcript

                                
                                
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 2019 R...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/609163/adamas-pharmaceuticals-adms-reports-q3-loss-lags-revenue-estimates
                            

                                
Adamas Pharmaceuticals (ADMS) Reports Q3 Loss, Lags Revenue Estimates

                                
                                
Adamas (ADMS) delivered earnings and revenue surprises of -10.00% a...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/595337/adamas-pharmaceuticals-adms-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q3-release
                            

                                
Adamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

                                
                                
Adamas (ADMS) possesses the right combination of the two key ingred...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/27/1922073/0/en/Adamas-to-Present-at-Upcoming-Cantor-Fitzgerald-Investor-Conference.html
                            

                                
Adamas to Present at Upcoming Cantor Fitzgerald Investor Conference

                                
                                
EMERYVILLE, Calif., Sept.  27, 2019  (GLOBE NEWSWIRE) -- Adamas Pha...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/17/1961609/0/en/Adamas-Announces-Top-Line-Results-from-INROADS-Phase-3-Trial-of-ADS-5102-for-Multiple-Sclerosis-Patients-with-Walking-Impairment.html
                            

                                
Adamas Announces Top-Line Results from INROADS Phase 3 Trial of ADS-5102 for Multiple Sclerosis Patients with Walking Impairment

                                
                                
- INROADS study achieved its primary endpoint (proportion of respon...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4311060-adamas-pharmaceuticals-inroads-data-will-make-break-2019
                            

                                
Adamas Pharmaceuticals: INROADS Data Will Make Or Break 2019

                                
                                
Adamas Pharmaceuticals: INROADS Data Will Make Or Break 2019


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/655797/implied-volatility-surging-for-adamas-pharmaceuticals-adms-stock-options
                            

                                
Implied Volatility Surging for Adamas Pharmaceuticals (ADMS) Stock Options

                                
                                
Investors need to pay close attention to Adamas Pharmaceuticals (AD...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/21/1951089/0/en/Adamas-to-Present-at-Upcoming-Evercore-ISI-and-Piper-Jaffray-Investor-Conferences.html
                            

                                
Adamas to Present at Upcoming Evercore ISI and Piper Jaffray Investor Conferences

                                
                                
EMERYVILLE, Calif., Nov.  21, 2019  (GLOBE NEWSWIRE) -- Adamas Phar...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4304099-adamas-pharmaceuticals-inc-adms-ceo-neil-mcfarlane-q3-2019-results-earnings-call-transcript
                            

                                
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 2019 Results - Earnings Call Transcript

                                
                                
Adamas Pharmaceuticals, Inc. (ADMS) CEO Neil McFarlane on Q3 2019 R...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/609163/adamas-pharmaceuticals-adms-reports-q3-loss-lags-revenue-estimates
                            

                                
Adamas Pharmaceuticals (ADMS) Reports Q3 Loss, Lags Revenue Estimates

                                
                                
Adamas (ADMS) delivered earnings and revenue surprises of -10.00% a...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/595337/adamas-pharmaceuticals-adms-expected-to-beat-earnings-estimates-what-to-know-ahead-of-q3-release
                            

                                
Adamas Pharmaceuticals (ADMS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

                                
                                
Adamas (ADMS) possesses the right combination of the two key ingred...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/27/1922073/0/en/Adamas-to-Present-at-Upcoming-Cantor-Fitzgerald-Investor-Conference.html
                            

                                
Adamas to Present at Upcoming Cantor Fitzgerald Investor Conference

                                
                                
EMERYVILLE, Calif., Sept.  27, 2019  (GLOBE NEWSWIRE) -- Adamas Pha...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.